FTDI
First Trust Direct Indexing’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,769
| Closed | -$2.62M | – | 622 |
|
|
2024
Q3 | $2.62M | Buy |
22,769
+128
| +0.6% | +$14.7K | 0.14% | 144 |
|
|
2024
Q2 | $2.41M | Buy |
22,641
+1,513
| +7% | +$161K | 0.15% | 127 |
|
|
2024
Q1 | $2.04M | Buy |
21,128
+568
| +3% | +$54.9K | 0.15% | 139 |
|
|
2023
Q4 | $2.08M | Buy |
20,560
+1,974
| +11% | +$199K | 0.19% | 117 |
|
|
2023
Q3 | $1.89M | Buy |
18,586
+1,941
| +12% | +$198K | 0.22% | 106 |
|
|
2023
Q2 | $1.68M | Buy |
16,645
+1,717
| +12% | +$173K | 0.19% | 118 |
|
|
2023
Q1 | $1.37M | Buy |
14,928
+576
| +4% | +$53K | 0.16% | 149 |
|
|
2022
Q4 | $1.3M | Sell |
14,352
-12,556
| -47% | -$1.14M | 0.17% | 145 |
|
|
2022
Q3 | $2.05M | Buy |
26,908
+1,284
| +5% | +$97.6K | 0.3% | 62 |
|
|
2022
Q2 | $2.17M | Buy |
25,624
+13,997
| +120% | +$1.18M | 0.3% | 68 |
|
|
2022
Q1 | $1.02M | Buy |
11,627
+3,746
| +48% | +$329K | 0.12% | 207 |
|
|
2021
Q4 | $689K | Sell |
7,881
-102
| -1% | -$8.92K | 0.09% | 281 |
|
|
2021
Q3 | $653K | Sell |
7,983
-69
| -0.9% | -$5.64K | 0.09% | 274 |
|
|
2021
Q2 | $735K | Buy |
+8,052
| New | +$735K | 0.11% | 243 |
|
|
2021
Q1 | – | Sell |
-445
| Closed | -$42K | – | 785 |
|
|
2020
Q4 | $42K | Buy |
+445
| New | +$42K | 0.01% | 790 |
|